Management of abdominal aortic prosthetic graft and endograft infections. A multidisciplinary update

Roberta Maria Antonello, Mario D'Oria, Marco Cavallaro, Franca Dore, Maria Assunta Cova, Maria Chiara Ricciardi, Manola Comar, Giuseppina Campisciano, Sandro Lepidi, Randall R De Martino, Stefano Chiarandini, Roberto Luzzati, Stefano Di Bella

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Abdominal aortic graft infections (AGIs) occur in 1–5% of aortic prosthetic placements. It can result in limb amputation, pseudo-aneurysm formation, septic emboli, aorto-enteric fistulae, septic shock and death. The most frequently involved pathogens are methicillin-susceptible Staphylococcus aureus, methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci, followed by Enterobacteriaceae and uncommon bacteria. In case of gut involvement the presence of fungi has to be considered. Computed tomography angiography is actually the gold standard diagnostic imaging but magnetic resonance is a valid alternative. Nuclear medicine imaging is commonly used to improve sensitivity and specificity. Signs and symptoms are often aspecific and blood cultures can be negative, requiring alternative ways to detect the microorganism responsible for infection, such as 16S rRNA gene sequencing and molecular rapid diagnostic tests. Curative surgical intervention is the first choice approach, with in-situ reconstruction providing by far the best outcome and xenopericardial bovine patch as a promising option. For patients unable to undergo major surgery, the outcome of conservative approach remains uncertain but usually provides for life-long suppressive therapy. However, in selected cases an attempt of stopping antibiotic treatment after 3–6 months can be done. Given the difficulty in their management, we performed a review of AGIs, in order to raise awareness on clinical presentation, current available diagnostic tools, prophylaxis, surgical and anti-infective treatment of AGIs.

Original languageEnglish (US)
JournalJournal of Infection and Chemotherapy
DOIs
StatePublished - Jan 1 2019

Fingerprint

Transplants
Infection
Methicillin
Molecular Pathology
Coagulase
Nuclear Medicine
Enterobacteriaceae
Diagnostic Imaging
Methicillin-Resistant Staphylococcus aureus
Septic Shock
Embolism
Staphylococcus
Amputation
rRNA Genes
Routine Diagnostic Tests
Signs and Symptoms
Fistula
Aneurysm
Staphylococcus aureus
Fungi

Keywords

  • Abdominal
  • Aorta
  • Blood vessel prosthesis
  • Graft infection
  • Vascular diseases

ASJC Scopus subject areas

  • Microbiology (medical)
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Management of abdominal aortic prosthetic graft and endograft infections. A multidisciplinary update. / Antonello, Roberta Maria; D'Oria, Mario; Cavallaro, Marco; Dore, Franca; Cova, Maria Assunta; Ricciardi, Maria Chiara; Comar, Manola; Campisciano, Giuseppina; Lepidi, Sandro; De Martino, Randall R; Chiarandini, Stefano; Luzzati, Roberto; Di Bella, Stefano.

In: Journal of Infection and Chemotherapy, 01.01.2019.

Research output: Contribution to journalReview article

Antonello, RM, D'Oria, M, Cavallaro, M, Dore, F, Cova, MA, Ricciardi, MC, Comar, M, Campisciano, G, Lepidi, S, De Martino, RR, Chiarandini, S, Luzzati, R & Di Bella, S 2019, 'Management of abdominal aortic prosthetic graft and endograft infections. A multidisciplinary update', Journal of Infection and Chemotherapy. https://doi.org/10.1016/j.jiac.2019.05.013
Antonello, Roberta Maria ; D'Oria, Mario ; Cavallaro, Marco ; Dore, Franca ; Cova, Maria Assunta ; Ricciardi, Maria Chiara ; Comar, Manola ; Campisciano, Giuseppina ; Lepidi, Sandro ; De Martino, Randall R ; Chiarandini, Stefano ; Luzzati, Roberto ; Di Bella, Stefano. / Management of abdominal aortic prosthetic graft and endograft infections. A multidisciplinary update. In: Journal of Infection and Chemotherapy. 2019.
@article{ba0568ed3e4743b9884411144268a3d6,
title = "Management of abdominal aortic prosthetic graft and endograft infections. A multidisciplinary update",
abstract = "Abdominal aortic graft infections (AGIs) occur in 1–5{\%} of aortic prosthetic placements. It can result in limb amputation, pseudo-aneurysm formation, septic emboli, aorto-enteric fistulae, septic shock and death. The most frequently involved pathogens are methicillin-susceptible Staphylococcus aureus, methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci, followed by Enterobacteriaceae and uncommon bacteria. In case of gut involvement the presence of fungi has to be considered. Computed tomography angiography is actually the gold standard diagnostic imaging but magnetic resonance is a valid alternative. Nuclear medicine imaging is commonly used to improve sensitivity and specificity. Signs and symptoms are often aspecific and blood cultures can be negative, requiring alternative ways to detect the microorganism responsible for infection, such as 16S rRNA gene sequencing and molecular rapid diagnostic tests. Curative surgical intervention is the first choice approach, with in-situ reconstruction providing by far the best outcome and xenopericardial bovine patch as a promising option. For patients unable to undergo major surgery, the outcome of conservative approach remains uncertain but usually provides for life-long suppressive therapy. However, in selected cases an attempt of stopping antibiotic treatment after 3–6 months can be done. Given the difficulty in their management, we performed a review of AGIs, in order to raise awareness on clinical presentation, current available diagnostic tools, prophylaxis, surgical and anti-infective treatment of AGIs.",
keywords = "Abdominal, Aorta, Blood vessel prosthesis, Graft infection, Vascular diseases",
author = "Antonello, {Roberta Maria} and Mario D'Oria and Marco Cavallaro and Franca Dore and Cova, {Maria Assunta} and Ricciardi, {Maria Chiara} and Manola Comar and Giuseppina Campisciano and Sandro Lepidi and {De Martino}, {Randall R} and Stefano Chiarandini and Roberto Luzzati and {Di Bella}, Stefano",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.jiac.2019.05.013",
language = "English (US)",
journal = "Journal of Infection and Chemotherapy",
issn = "1341-321X",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Management of abdominal aortic prosthetic graft and endograft infections. A multidisciplinary update

AU - Antonello, Roberta Maria

AU - D'Oria, Mario

AU - Cavallaro, Marco

AU - Dore, Franca

AU - Cova, Maria Assunta

AU - Ricciardi, Maria Chiara

AU - Comar, Manola

AU - Campisciano, Giuseppina

AU - Lepidi, Sandro

AU - De Martino, Randall R

AU - Chiarandini, Stefano

AU - Luzzati, Roberto

AU - Di Bella, Stefano

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Abdominal aortic graft infections (AGIs) occur in 1–5% of aortic prosthetic placements. It can result in limb amputation, pseudo-aneurysm formation, septic emboli, aorto-enteric fistulae, septic shock and death. The most frequently involved pathogens are methicillin-susceptible Staphylococcus aureus, methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci, followed by Enterobacteriaceae and uncommon bacteria. In case of gut involvement the presence of fungi has to be considered. Computed tomography angiography is actually the gold standard diagnostic imaging but magnetic resonance is a valid alternative. Nuclear medicine imaging is commonly used to improve sensitivity and specificity. Signs and symptoms are often aspecific and blood cultures can be negative, requiring alternative ways to detect the microorganism responsible for infection, such as 16S rRNA gene sequencing and molecular rapid diagnostic tests. Curative surgical intervention is the first choice approach, with in-situ reconstruction providing by far the best outcome and xenopericardial bovine patch as a promising option. For patients unable to undergo major surgery, the outcome of conservative approach remains uncertain but usually provides for life-long suppressive therapy. However, in selected cases an attempt of stopping antibiotic treatment after 3–6 months can be done. Given the difficulty in their management, we performed a review of AGIs, in order to raise awareness on clinical presentation, current available diagnostic tools, prophylaxis, surgical and anti-infective treatment of AGIs.

AB - Abdominal aortic graft infections (AGIs) occur in 1–5% of aortic prosthetic placements. It can result in limb amputation, pseudo-aneurysm formation, septic emboli, aorto-enteric fistulae, septic shock and death. The most frequently involved pathogens are methicillin-susceptible Staphylococcus aureus, methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci, followed by Enterobacteriaceae and uncommon bacteria. In case of gut involvement the presence of fungi has to be considered. Computed tomography angiography is actually the gold standard diagnostic imaging but magnetic resonance is a valid alternative. Nuclear medicine imaging is commonly used to improve sensitivity and specificity. Signs and symptoms are often aspecific and blood cultures can be negative, requiring alternative ways to detect the microorganism responsible for infection, such as 16S rRNA gene sequencing and molecular rapid diagnostic tests. Curative surgical intervention is the first choice approach, with in-situ reconstruction providing by far the best outcome and xenopericardial bovine patch as a promising option. For patients unable to undergo major surgery, the outcome of conservative approach remains uncertain but usually provides for life-long suppressive therapy. However, in selected cases an attempt of stopping antibiotic treatment after 3–6 months can be done. Given the difficulty in their management, we performed a review of AGIs, in order to raise awareness on clinical presentation, current available diagnostic tools, prophylaxis, surgical and anti-infective treatment of AGIs.

KW - Abdominal

KW - Aorta

KW - Blood vessel prosthesis

KW - Graft infection

KW - Vascular diseases

UR - http://www.scopus.com/inward/record.url?scp=85066829370&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066829370&partnerID=8YFLogxK

U2 - 10.1016/j.jiac.2019.05.013

DO - 10.1016/j.jiac.2019.05.013

M3 - Review article

C2 - 31182331

AN - SCOPUS:85066829370

JO - Journal of Infection and Chemotherapy

JF - Journal of Infection and Chemotherapy

SN - 1341-321X

ER -